GCC REACH: 2 YEARS OF IMPACT (2023–2025)
Accelerating Biomedical Innovation Across Texas
Key Metrics Bar
26
63
Institutions Engaged
Tech Feedbacks
19
29
Stage 2 Projects
Industry Experts
3
37
Cohorts Launched
Strategic Advisors
$900K
18
CRIPT Funding
Interns Trained
Cohort Progress Snapshot
(Completed)
Cohort 1
$51.4K
Notable Technologies
Funding
Status
Oral patch, Nanoparticles, Cancer therapy
(Completed)
Cohort 2
$86.7K
CAR-T, Brain injury therapy, Breast reconstruction
(Completed)
Cohort 3
$207K
eRNA therapeutics, Viral detection, Breast cancer therapy
Funding TBD
Cohort 4
(In Progress)
eRNA therapeutics, Viral detection, Breast cancer therapy
$51.4K
$86.7K
$207K
Commercialization Pipeline
TFF
19 plans drafted
4 phase ||- ready
11 milestone-funded projects
$900K CPRIT secured
Human Capital Development
18
NUCLEATE INTERNS EMBEDDED
63
PROJECT LEADS RECEIVED DETAILED WRITTEN FEEDBACK
ENGAGEMENT WITH NIH SEED, FDA, REGULATORY EXPERTS
STRATEGIC ADVISORY TEAMS FOR EVERY STAGE 2 PROJECT
Reach & Ecosystem Impact
2,067+
newsletter recipients
Inclusion:
HBCU & community health workshops
Media coverage:
Houston Innovation Map
7 ‘Lunch & Learn’
and outreach events
